Skip to main content
. 2020 Apr 6;175(1):87–97. doi: 10.1093/toxsci/kfaa023

Table 1.

Summary of Endogenous Metabolite Changes in APAP-treated Pigs Relative to Controls Across All Matrices at the Pre- and Post-ALF Timepoints

Sample Matrix Metabolite Changes Pre-ALF p Value Adjusted p Value (q) Metabolite Changes Post-ALF p Value Adjusted p Value (q)
Plasma Pyruvate .0001 .0002 Pyruvate .0005 .0006
Lactate .002 .0012 Lactate <.0001 .0002
Glucose .0172 .009 Glucose <.0001 <.0001
Glutamine .0002 .0007 Glutamine .0018 .0037
Tyrosine <.0001 .0002 Alanine .0047 .308
Citrate <.0001 .0002
Urine Dimethylamine .0637 .0418 Dimethylamine .0012 .0046
Trimethylamine <.0001 .0001 Trimethylamine <.0001 .0001
Choline .0025 .0286 Glucose <.0001 .0004
Creatine .0003 .0011 Creatine .0075 .0073
Creatinine .0006 .0068
Lactate .0001 .0012
Liver No significant changes Creatine <.0001 <.0001
Isobutyrate .0117 .0245
Succinate <.0001 <.0001
Inosine .0088 .0184
Alanine a .0236 .0743
Lactate a .224 .706
Kidney No data Glucose .0003 Not applicable
Sucinate .0074
Alanine .0104

ALF occurred at 17.5 ± 2.7-h postonset of APAP treatment. Pre-ALF refers to all time points prior to ALF and post-ALF to all time points after ALF. Normal type, metabolite decrease; Bold, metabolite increase.

a

Changes not statistically significant.